Diagnostics and research stocks with the lowest EV/EBIT

Ranked

25

of 74 diagnostics and research stocks we cover

Median

30.5×

Lowest

0.4×

ADVB

Range

0.4× to 129×

#	Company	EV/EBIT	PE	Operating margin	Market cap
1	ADVBAdvanced Biomed	0.4×	n/m	n/m	$5.2M
2	ICCCImmucell	14.2×	128×	12.6%	$93.1M
3	DGXQuest Diagnostics	19.5×	25.7×	14.1%	$26.7B
4	LNTHLantheus	20.6×	24.2×	19.4%	$6.5B
5	LHLabcorp	21.6×	27.2×	10.4%	$26.7B
6	BRKRBruker	23.1×	n/m	−0.9%	$8.8B
7	CRLCharles River Laboratories International	26.0×	n/m	2.3%	$16.5B
8	VCYTVeracyte	27.2×	34.2×	18.8%	$3.9B
9	IQVIQVIA	27.3×	34.7×	13.0%	$46B
10	CDNACareDx	29.3×	33.4×	23.6%	$3.6B
11	IDXXIDEXX Laboratories	30.3×	39.4×	32.0%	$44.1B
12	MTDMettler-Toledo International	30.5×	37.6×	27.8%	$33.5B
13	AVTRAvantor	30.5×	n/m	−4.6%	$11.7B
14	AAgilent Technologies	31.1×	34.0×	22.2%	$48.8B
15	MEDPMedpace	31.4×	39.2×	21.0%	$18.7B
16	DHRDanaher	34.5×	40.9×	20.4%	$162B
17	TMOThermo Fisher Scientific	34.7×	35.5×	17.9%	$249.1B
18	NRCNRC Health	38.8×	87.7×	10.5%	$485.1M
19	BIOBio-Rad Laboratories	40.2×	44.8×	2.1%	$9.9B
20	RVTYRevvity	46.0×	75.6×	12.3%	$17.7B
21	ILMNIllumina	47.7×	50.1×	19.6%	$40.7B
22	CAICaris Life Sciences	56.4×	86.5×	15.5%	$9B
23	RDNTRadNet	72.1×	n/m	3.1%	$5.5B
24	BLLNBillionToOne	107×	166×	10.9%	$5.1B
25	WATWaters	129×	113×	7.1%	$44.6B

Not ranked: 44 with a loss over the last year, 3 with not a meaningful number. 2 companies whose data behind this number has a caveat are left out until it is checked.

A ranking of numbers, not a recommendation. A low multiple can be a bargain or a business in trouble: open the company to see which.